Aclarion announces first commercial agreement with scripps health

Agreement expands access to nociscan technology for leading spine physicians and more than 3.2m people in the greater san diego metro area nociscan leverages mr spectroscopy (mrs) and augmented intelligence (ai) to identify sources of chronic low back pain broomfield, colo., march 03, 2025 (globe newswire) -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, announced today it has established a commercial agreement with scripps health in san diego, ca.
ACON Ratings Summary
ACON Quant Ranking